Clinical Evaluation of Heart Failure

Heart Failure: A Companion to Braunwald's Heart Disease Expert Consult

Volumn , Issue , 2010, Pages 511-525

  Tang, W H Wilson ^a   Francis, Gary S ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84938862462     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5895-3.10035-X     Document Type: Chapter

References (87)

1. Hunt S.A., Abraham W.T., Chin M.H., et al. Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119(14):e391-e479.
2. Butler J., Kalogeropoulos A., Georgiopoulou V., et al. Incident heart failure prediction in the elderly: the Health ABC Heart Failure score. Circ Heart Fail 2008, 1:125-133.
3. Criteria Committee of the New York Heart Association Nomenclature and criteria for diagnosis of diseases of the heart and great vessels 1994, Little, Brown, Boston. ed 9.
4. Mosterd A., Deckers J.W., Hoes A.W., et al. Classification of heart failure in population based research: an assessment of six heart failure scores. Eur J Epidemiol 1997, 13:491-502.
5. Lewis E.F., Johnson P.A., Johnson W., et al. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant 2001, 20:1016-1024.
6. Tsuyuki R.T., McKelvie R.S., Arnold M.O., et al. Acute precipitants of congestive heart failure exacerbations. Arch Intern Med 2001, 161:2337-2342.
7. Fonarow G.C., Abraham W.T., Albert N.M., et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 2008, 168:847-854.
8. Rector T.S., Cohn J.N. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo controlled trial of pimobendan. Am Heart J 1992, 124:1017.
9. Green C.P., Porter C.B., Bresnahan D.R., et al. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 2000, 35:1245-1255.
10. ACC/AHA guidelines for the management of patients with valvular heart disease A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 1998, 32:1486-1588.
11. Benge W., Litchfield R.L., Marcus M.L. Exercise capacity in patients with severe left ventricular dysfunction. Circulation 1980, 61:955-959.
12. Franciosa J.A., Park M., Levine T.B. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981, 47:33-39.
13. Franciosa J.A., Ziesche S., Wilen M. Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization. Am J Med 1979, 67:460-466.
14. Francis G.S., Goldsmith S.R., Cohn J.N. Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. Am Heart J 1982, 104(4 Pt 1):725-731.
15. Fink L.I., Wilson J.R., Ferraro N. Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure. Am J Cardiol 1986, 57:249-253.
16. Stevenson L.W., Perloff J.K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989, 261:884-888.
17. Mancini D.M., Henson D., LaManca J., et al. Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation 1992, 86:909-918.
18. Clark A.L., Poole-Wilson P.A., Coats A.J. Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 1996, 28:1092-1102.
19. MacGowan G.A., Cecchetti A., Murali S. Ventilatory drive during exercise in congestive heart failure. J Card Fail 1997, 3:257-262.
20. Wasserman K. Dyspnea on exertion. Is it the heart or the lungs?. JAMA 1982, 248:2039-2043.
21. Wilson J.R., Mancini D.M. Factors contributing to the exercise limitation of heart failure. J Am Coll Cardiol 1993, 22(4 Suppl A):93A-98A.
22. Chua T.P., Clark A.L., Amadi A.A., et al. Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1996, 27:650-657.
23. Ponikowski P., Francis D.P., Piepoli M.F., et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 2001, 103:967-972.
24. Johnson R.L. Gas exchange efficiency in congestive heart failure II. Circulation 2001, 103:916-918.
25. Wasserman K. The peripheral circulation and lactic acid metabolism in heart, or cardiovascular, failure. Circulation 1989, 80:1084-1086.
26. Piepoli M., Clark A.L., Volterrani M., et al. Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. Circulation 1996, 93:940-952.
27. Mancini D.M., Coyle E., Coggan A., et al. Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 1989, 80:1338-1346.
28. Mancini D.M., Ferraro N., Tuchler M., et al. Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance. Am J Cardiol 1988, 62:1234-1240.
29. Massie B., Conway M., Yonge R., et al. Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation 1987, 76:1009-1019.
30. Massie B.M., Conway M., Yonge R., et al. 31P Nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure. Am J Cardiol 1987, 60:309-315.
31. Wilson J.R., Fink L., Maris J., et al. Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation 1985, 71:57-62.
32. Sullivan M.J., Green H.J., Cobb F.R. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990, 81:518-527.
33. Mancini D.M., Walter G., Reichek N., et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992, 85:1364-1373.
34. Drexler H., Riede U., Munzel T., et al. Alterations of skeletal muscle in chronic heart failure. Circulation 1992, 85:1751-1759.
35. Schaefer S., Gober J.R., Schwartz G.G., et al. In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease. Am J Cardiol 1990, 65:1154-1161.
36. Sullivan M.J., Green H.J., Cobb F.R. Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity. Circulation 1991, 84:1597-1607.
37. Working Group on Cardiac Rehabilitation & Exercice Physiology and Working Group on Heart Failure of the European Society of Cardiology. Recommendations for exercise training in chronic heart failure patients. Eur Heart J 2001, 22:125-135.
38. Fleg J.L., Pina I.L., Balady G.J., et al. Assessment of functional capacity in clinical and research applications: an advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation 2000, 102:1591-1597.
39. Minotti J.R., Massie B.M. Exercise training in heart failure patients. Does reversing the peripheral abnormalities protect the heart?. Circulation 1992, 85:2323-2325.
40. Sullivan M.J., Higginbotham M.B., Cobb F.R. Exercise training in patients with chronic heart failure delays ventilatory anaerobic threshold and improves submaximal exercise performance. Circulation 1989, 79:324-329.
41. Sullivan M.J., Higginbotham M.B., Cobb F.R. Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects. Circulation 1988, 78:506-515.
42. Nohria A., Lewis E., Stevenson L.W. Medical management of advanced heart failure. JAMA 2002, 287:628-640.
43. Drazner M.H., Hellkamp A.S., Leier C.V., et al. Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial. Circ Heart Fail 2008, 1:170-177.
44. Economides E., Stevenson L.W. The jugular veins: knowing enough to look. Am Heart J 1998, 136:6-9.
45. Perloff J.K. The jugular venous pulse and third heart sound in patients with heart failure. N Engl J Med 2001, 345:612-614.
46. Wiese J. The abdominojugular reflux sign. Am J Med 2000, 109:59-61.
47. Mullens W., Abrahams Z., Skouri H.N., et al. Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?. J Am Coll Cardiol 2008, 51:300-306.
48. Tribouilloy C.M., Enriquez-Sarano M., Mohty D., et al. Pathophysiologic determinants of third heart sounds: a prospective clinical and Doppler echocardiographic study. Am J Med 2001, 111:96-102.
49. Drazner M.H., Rame J.E., Stevenson L.W., et al. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001, 345:574-581.
50. Drazner M.H., Rame J.E., Dries D.L. Third heart sound and elevated jugular venous pressure as markers of the subsequent development of heart failure in patients with asymptomatic left ventricular dysfunction. Am J Med 2003, 114:431-437.
51. Lucas C., Johnson W., Hamilton M.A., et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 2000, 140:840-847.
52. Lee Y.C., Sutton F.J. Pulsus alternans in patients with congestive cardiomyopathy. Circulation 1982, 65:1533-1534.
53. Anker S.D., Ponikowski P., Varney S., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997, 349:1050-1053.
54. Anker S.D., Rauchhaus M. Insights into the pathogenesis of chronic heart failure: immune activation and cachexia. Curr Opin Cardiol 1999, 14:211-216.
55. Dunlay S.M., Weston S.A., Redfield M.M., et al. Tumor necrosis factor-alpha and mortality in heart failure: a community study. Circulation 2008, 118:625-631.
56. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112(12):e154-e235.
57. Heart Failure Society of America Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 2006, 12:10-38.
58. Tang W.H., Tong W., Jain A., et al. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol 2008, 51:569-576.
59. Tang W.H., Francis G.S., Morrow D.A., et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation 2007, 116(5):e99-e109.
60. Gheorghiade M., Bonow R.O. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 1998, 97:282-289.
61. Baba R., Tsuyuki K., Kimura Y., et al. Oxygen uptake efficiency slope as a useful measure of cardiorespiratory functional reserve in adult cardiac patients. Eur J Appl Physiol Occup Physiol 1999, 80:397-401.
62. Brookes C.I., Hart P., Keogh B.E., et al. Angiography and the aetiology of heart failure. Postgrad Med J 1995, 71:480-482.
63. Bortman G., Sellanes M., Odell D.S., et al. Discrepancy between pre- and post-transplant diagnosis of end-stage dilated cardiomyopathy. Am J Cardiol 1994, 74:921-924.
64. Smith R.F., Johnson G., Ziesche S., et al. Functional capacity in heart failure. Comparison of methods for assessment and their relation to other indexes of heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993, 87(6 Suppl):VI88-VI93.
65. Florea V.G., Henein M.Y., Anker S.D., et al. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure. Eur Heart J 2000, 21:146-153.
66. Chua T.P., Ponikowski P., Harrington D., et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997, 29:1585-1590.
67. Lang C.C., Agostoni P., Mancini D.M. Prognostic significance and measurement of exercise-derived hemodynamic variables in patients with heart failure. J Card Fail 2007, 13:672-679.
68. Robbins M., Francis G., Pashkow F.J., et al. Ventilatory and heart rate responses to exercise: better predictors of heart failure mortality than peak oxygen consumption. Circulation 1999, 100:2411-2417.
69. Weber K.T., Kinasewitz G.T., Janicki J.S., et al. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation 1982, 65:1213-1223.
70. Russell S.D., McNeer F.R., Higginbotham M.B. Exertional dyspnea in heart failure: a symptom unrelated to pulmonary function at rest or during exercise. Duke University Clinical Cardiology Studies (DUCCS) Exercise Group. Am Heart J 1998, 135:398-405.
71. Johnson R.L. Gas exchange efficiency in congestive heart failure. Circulation 2000, 101:2774-2776.
72. Francis G.S., Rector T.S. Maximal exercise tolerance as a therapeutic end point in heart failure-are we relying on the right measure?. Am J Cardiol 1994, 73:304-306.
73. Guyatt G.H., Sullivan M.J., Thompson P.J., et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985, 132:919-923.
74. Morales F.J., Martinez A., Mendez M., et al. A shuttle walk test for assessment of functional capacity in chronic heart failure. Am Heart J 1999, 138(2 Pt 1):291-298.
75. Opasich C., Pinna G.D., Mazza A., et al. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice?. Eur Heart J 2001, 22:488-496.
76. Sharma R., Anker S.D. The 6-minute walk test and prognosis in chronic heart failure-the available evidence. Eur Heart J 2001, 22:445-448.
77. Mancini D.M., Eisen H., Kussmaul W., et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991, 83:778-786.
78. Mehra M.R., Kobashigawa J., Starling R., et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 2006, 25:1024-1042.
79. Lauer M.S., Francis G.S., Okin P.M., et al. Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA 1999, 281:524-529.
80. Binanay C., Califf R.M., Hasselblad V., et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 2005, 294:1625-1633.
81. Hrobon P., Kuntz K.M., Hare J.M. Should endomyocardial biopsy be performed for detection of myocarditis? A decision analytic approach. J Heart Lung Transplant 1998, 17:479-486.
82. Mason J.W., O'Connell J.B., Herskowitz A., et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995, 333:269-275.
83. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999, 99:1091-1100.
84. Cooper L.T., Baughman K.L., Feldman A.M., et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007, 116:2216-2233.
85. McCarthy R.E., Boehmer J.P., Hruban R.H., et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000, 342:690-695.
86. Cooper L.T., Berry G.J., Shabetai R. Idiopathic giant-cell myocarditis-natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 1997, 336:1860-1866.
87. Hershberger R.E., Lindenfeld J., Mestroni L., et al. Genetic evaluation of cardiomyopathy-a Heart Failure Society of America practice guideline. J Card Fail 2009, 15:83-97.